HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Suehara Selected Research

Arginine (L-Arginine)

10/2016Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Suehara Research Topics

Disease

46Neoplasms (Cancer)
11/2023 - 01/2004
13Sarcoma (Soft Tissue Sarcoma)
11/2023 - 08/2006
10Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2024 - 03/2008
10Adenocarcinoma of Lung
04/2023 - 12/2012
10Neoplasm Metastasis (Metastasis)
03/2021 - 05/2011
6Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 09/2008
4Lung Neoplasms (Lung Cancer)
03/2022 - 09/2014
4Leiomyosarcoma
04/2021 - 08/2006
4Microsatellite Instability
01/2021 - 01/2017
4Giant Cell Tumors (Giant Cell Tumor)
01/2019 - 10/2011
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 11/2019
2Desmoplastic Small Round Cell Tumor
01/2022 - 04/2004
2Ewing Sarcoma (Sarcoma, Ewing)
10/2021 - 03/2018
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2021 - 01/2021
2Neurofibrosarcoma (MPNST)
04/2021 - 09/2008
2Carcinogenesis
01/2021 - 11/2016
2Melanoma (Melanoma, Malignant)
01/2021 - 10/2016
2Adenocarcinoma
09/2020 - 01/2018
2Alveolar Soft Part Sarcoma
01/2017 - 10/2016
2Desmoplastic Fibroma
05/2014 - 01/2013
2Synovial Sarcoma (Synovioma)
05/2011 - 09/2008
1Thymoma (Thymic Carcinoma)
01/2023
1Neutropenia
11/2022
1Febrile Neutropenia
11/2022
1Lymphatic Metastasis
01/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2020
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2020
1Giant Cell Tumor of Bone
01/2020
1Stomach Neoplasms (Stomach Cancer)
01/2018
1Turcot syndrome
01/2017

Drug/Important Bio-Agent (IBA)

20Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2006
16Proteins (Proteins, Gene)FDA Link
01/2023 - 08/2006
8Phosphotransferases (Kinase)IBA
11/2023 - 05/2014
7Tyrosine Kinase InhibitorsIBA
10/2021 - 09/2014
5DNA (Deoxyribonucleic Acid)IBA
11/2023 - 05/2014
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2023 - 12/2012
4RNA (Ribonucleic Acid)IBA
11/2023 - 05/2014
4DenosumabFDA Link
01/2020 - 12/2014
4ParaffinIBA
12/2019 - 06/2013
4Formaldehyde (Formol)FDA Link
12/2019 - 06/2013
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2024 - 05/2014
3tyrosine receptor (receptor, tyrosine)IBA
11/2023 - 05/2014
3Thyroid Nuclear Factor 1IBA
04/2023 - 01/2021
3Tyrosine (L-Tyrosine)FDA Link
04/2021 - 03/2015
3Messenger RNA (mRNA)IBA
04/2021 - 12/2012
3Immune Checkpoint InhibitorsIBA
03/2021 - 10/2016
3Protein Isoforms (Isoforms)IBA
01/2021 - 08/2006
3Gefitinib (Iressa)FDA Link
11/2019 - 01/2015
3TropomyosinIBA
10/2019 - 08/2006
3Telomerase (Telomerase Reverse Transcriptase)IBA
01/2016 - 01/2015
3CollagenIBA
01/2015 - 01/2013
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2024 - 03/2015
2NucleotidesIBA
11/2023 - 04/2019
2Anaplastic Lymphoma KinaseIBA
11/2023 - 09/2014
2CrizotinibIBA
08/2023 - 09/2014
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 10/2016
2IfosfamideFDA LinkGeneric
11/2022 - 04/2004
2larotrectinibIBA
11/2021 - 10/2019
2MucinsIBA
03/2021 - 01/2021
2Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2020 - 03/2015
2GlypicansIBA
09/2020 - 01/2018
2Transcription Factor 4IBA
11/2019 - 01/2018
2cabozantinibIBA
01/2017 - 06/2013
2Monoclonal AntibodiesIBA
06/2013 - 01/2010
1GemcitabineFDA Link
11/2022
1Docetaxel (Taxotere)FDA Link
11/2022
1Transcription Factors (Transcription Factor)IBA
03/2022
1Cetuximab (Erbitux)FDA Link
01/2022
1AfatinibIBA
01/2022
1B7-H1 AntigenIBA
11/2021
1entrectinibIBA
11/2021
1Carcinoembryonic AntigenIBA
11/2021
1Cell-Free Nucleic AcidsIBA
10/2021
1Indicators and Reagents (Reagents)IBA
04/2021
1Immunoglobulins (Immunoglobulin)IBA
03/2021
1phosphatidyl-N-monomethylaminoethanolIBA
01/2021
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
11/2020
1pazopanibFDA Link
11/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2020
1nintedanibIBA
07/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2020
1osimertinibIBA
01/2020
1Insulin (Novolin)FDA Link
01/2020
1pembrolizumabIBA
02/2019
1Trastuzumab (Herceptin)FDA Link
01/2018
1Fetal Proteins (Fetoprotein)IBA
01/2018
1GlycogenIBA
01/2018
1Mucin-1 (CA 15-3 Antigen)IBA
01/2018
1PromegaIBA
01/2017
1Dasatinib (BMS 354825)FDA Link
01/2017
1PENTAIBA
01/2017
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
11/2016

Therapy/Procedure

21Therapeutics
11/2023 - 08/2006
10Drug Therapy (Chemotherapy)
11/2023 - 04/2004
3Immunotherapy
01/2022 - 03/2021
3Precision Medicine
06/2021 - 04/2019
3Curettage
01/2020 - 10/2011
2Radiotherapy
01/2021 - 11/2020
1Preoperative Period
11/2022
1Transplantation
01/2021